scout
|Videos|April 28, 2017

How Cabozantinib is Being Used in Practice for Patients With RCC

Daniel James George, MD, professor of Medicine, professor in Surgery, Duke University School of Medicine, discusses how cabozantinib (Cabometyx) is currently being used in practice for patients with renal cell carcinoma (RCC).

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME